Last year, the U.S. Senate Special Committee on Aging launched a bipartisan effort to expose the public health and national security risks America’s overreliance on foreign-made generic drugs poses to ...
Sara (Olga Kurylenko) is locked in a dire battle of wits in Misdirection. She's come to the home of Daniel Blume (Frank Grillo) with her boyfriend, Jason (Oliver Trevena), with the hopes of robbing ...
New Jersey has joined 42 other states in suing global pharmaceutical company Novartis and its spin-off Sandoz for engaging in what they describe as “one of the most egregious examples of ...
Critics Have Issues With The Wrecking Crew, But They Agree On Dave Bautista And Jason Momoa The Wrecking Crew Left Me With Two Issues Concerning The Villain There's One Thing The Wrecking Crew Gets ...
Dearest gentle reader, the ton is filled with excitement and curiosity following Netflix’s latest drop: Bridgerton Season 4 Part 1. The horse-drawn carriages, corsets and masquerade balls are back in ...
The initial Rotten Tomatoes score for Melania Trump's new documentary fell short of her husband's approval ratings, opening at 8%. "Melania" hit theaters nationwide Friday, Jan. 30, following the ...
Mohammed Ali Naqvi's Sundance-premiering doc chronicles a dramatic 2023 gondola accident in rural Pakistan. By Richard Lawson In 2023, a gondola carrying eight people — six of them teenagers on their ...
The U.S. Supreme Court has decided to hear a case between Amarin Pharma and generic drug maker Hikma that puts so-called “skinny labels” back in the spotlight. The high court has agreed to make the ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...
No one ever went wrong throwing together a piano, some upbeat songs and a bunch of kids wondering whether the show really must go on. It’s a mainstay of musical theater. It just doesn’t always happen ...
Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...